Answers are grounded in this paper and cite their sources.
Current polycyclic aromatic hydrocarbon (PAH) risk assessments focusing on isolated cardiometabolic endpoints may overlook compounded morbidity burdens, and the potential role of biological aging and antioxidant dietary strategies in developing cardiometabolic multimorbidity (CMM) remains unclear. We aimed to utilize an integrative approach to explore the association between PAHs and CMM, as well as potential mechanisms and interventions. Utilizing National Health and Nutrition Examination Survey cross-sectional data (NHANES: 2005–2016), three statistical models were utilized to examine the association between PAHs and CMM and further explore the mediating role of biological aging acceleration (BAA) and the moderating role of the composite dietary antioxidant index (CDAI), utilizing a bioinformatics approach to identify key targets and potential pathways. Our multi-model analysis revealed significant linear positive association between PAHs exposures and CMM, with 2-hydroxynapthalene (2-OHNAP), 2-hydroxyfluorene (2-OHFLU), and 3-hydroxyfluorene (3-OHFLU) emerging as the predominant contributor ( P < 0.05). Causal mediation analysis identified BAA mediating 8.13 % of the PAH-CMM association. Additionally, the association between PAHs and CMM appears to be stronger in individuals with lower CDAI levels. Bioinformatic interrogation of stroke pathogenesis (as a CMM endpoint) through differential expression analysis and functional enrichment identified four key genes (IL6, CASP3, TP53, and TGFB1) that orchestrate PAH-induced atherosclerosis via the AGE-RAGE signaling pathway. The evidence from our study emphasizes PAHs exposure as critical exogenous driver of CMM pathogenesis, partially mediated through accelerated biological aging mechanisms, while highlighting nutritional antioxidants as potential targets for future interventions. Our findings advocate environmental health policies targeting PAHs reduction and inspire the precision nutrition interventions for high-risk populations. • PAHs exposure was connected to an increased CMM risk. • Mixture models revealed the associations between mixed PAHs and both CMM and CMD. • Convergent evidence from pathway-network analyses delineates potential pathogenic mechanisms. • BAA may play a partial mediating role in the association between PAHs and CMM.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: